543902 announcements Retina announcements and dividends declared BSE
Retina Complete list of announcements declared & dividend announcements by Retina 543902
Retina 543902 listed on BSE and deals inAnnouncements and dividends declared by Retina 543902
Second Sight Medical stock skyrockets 8-fold in 2 days after FDA approves retinal prosthesis system
Shares of Second Sight Medical Products Inc. soared 104.2% on heavy volume in midday trading Monday, bringing its two-day gain to 728.7%, after the Food and Drug Administration approved the company's Argus 2s Retinal Prosthesis System for the treatment of
Announcement as on 08 March 2021
Announcements by Retina first page | Prev page |
543902 Retina current price & indicator signals
Recent prices of 543902 Retina are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 21 Tue Apr 2026 | 56.00 | 56.00 to 56.00 | 1.58% | 0.04 times |
| 20 Mon Apr 2026 | 55.13 | 52.10 to 56.50 | -1.2% | 1.18 times |
| 17 Fri Apr 2026 | 55.80 | 55.70 to 56.85 | -6.41% | 0.7 times |
| 16 Thu Apr 2026 | 59.62 | 51.51 to 61.70 | 14.48% | 2.19 times |
| 15 Wed Apr 2026 | 52.08 | 50.51 to 52.80 | 1.24% | 0.66 times |
| 13 Mon Apr 2026 | 51.44 | 49.00 to 54.00 | 3.38% | 0.57 times |
| 10 Fri Apr 2026 | 49.76 | 48.75 to 52.00 | -6.2% | 0.48 times |
| 09 Thu Apr 2026 | 53.05 | 51.90 to 54.00 | 2.02% | 1.01 times |
| 08 Wed Apr 2026 | 52.00 | 51.50 to 57.80 | 1.46% | 1.36 times |
| 07 Tue Apr 2026 | 51.25 | 50.82 to 54.50 | -4.21% | 1.05 times |
| 06 Mon Apr 2026 | 53.50 | 53.00 to 54.90 | -0.15% | 0.79 times |
| 01 Wed Apr 2026 | 53.58 | 52.20 to 55.70 | -2.49% | 0.48 times |
Videos related to: 543902 announcements Retina announcements and dividends declared BSE
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- BSE Screeners
- BSE Daily Screener
- BSE Weekly Screener
- BSE Monthly Screener
- Support & Resistance
- BSE Shares Near Support
- BSE Shares Near Resistance


